Novartis Year Profit Up 15 Pct
684039
BASEL, Switzerland  - Net profits at Novartis AG  rose by a lower-than-expected 15 percent last year as  restructuring costs weighed, the company reported on Thursday,  but the world's sixth biggest drugmaker said it expects record  sales and profits in 2005.
302016
Oil giant BP reports a 15% rise in annual profits, buoyed by high crude prices in the first half of the year.
734292
The cardiovascular device maker said its second-quarter profit, excluding charges, was $271 million, or 18 cents per share, compared with $412 million, or 31 cents per share, a year ago.
713279
Swiss pharmaceuticals giant Novartis AG on Thursday reported a 21 percent rise in third-quarter net profit to $1.55 billion.
732908
The company said fourth-quarter earnings rose 17 percent on higher sales of its Enbrel arthritis drug and Prevnar vaccine, but said generic competition would hit 2008 profit.
525091
Starwood Hotels & Resorts Worldwide Inc. posted a 15 percent rise in quarterly profit on Thursday as business travel and visitors to the United States increased.
295237
Novartis stays on track with its third-quarter results.
61085
Strong summer traffic on its trans-Atlantic flights helped boost Continental Airlinesâ profit by 15 percent in the second quarter.
582415
The Royal Bank of Scotland (RBS) said Thursday that net profit rose by 15 percent to 6.2 billion pounds in 2006, boosted by its investment banking arm.
11993
Anglo-Swedish drugs giant AstraZeneca reported a 14 percent rise in third quarter pre-tax profit and said it was on track to hit earnings estimates for the full year.
227150
Hormel Foods Corp.  on Thursday  said quarterly profit rose 15 percent as strength in areas like  grocery products and specialty foods more than offset weakness  in refrigerated foods and Jennie-O turkey.
276583
Swiss pharmaceutical maker Novartis AG said Tuesday it has received U.
10796
Net profit in the fourth quarter rose to 753 million euros ($1.09 billion), helped by sales of the blood-thinner Plavix in the United States and cost-cutting measures, the company said.
261903
Genentech Inc.  on Wednesday said third-quarter earnings rose 50 percent, spurred by growth in new colon cancer treatment Avastin and strong sales of its older drugs, and raised its full-year profit forecast.
231982
The EchoStar Communications Corporation said fourth-quarter profit rose 15 percent as a result of an increase in subscribers.
230439
LONDON (CBS.MW) -- European drugmakers Novartis, Schering and Sanofi-Aventis on Thursday all posted rising third-quarter sales, helped by sales lifts in the companies&#39; key products.
235034
BASEL, Switzerland  - Net profit at Roche Holding AG  rose 34 percent to 9.17 billion Swiss francs ($7.33 billion) in 2006 due to strong sales of cancer treatments Herceptin and Avastin, just ahead of analysts' expectations.